nodes	percent_of_prediction	percent_of_DWPC	metapath
Buprenorphine—ABCG2—Conjugated Estrogens—osteoporosis	0.045	0.07	CbGbCtD
Buprenorphine—ABCG2—Estradiol—osteoporosis	0.0395	0.0615	CbGbCtD
Buprenorphine—CYP1A2—Estropipate—osteoporosis	0.0392	0.061	CbGbCtD
Buprenorphine—CYP2C9—Estropipate—osteoporosis	0.0353	0.055	CbGbCtD
Buprenorphine—CYP2C8—Raloxifene—osteoporosis	0.0338	0.0526	CbGbCtD
Buprenorphine—CYP2C8—Ethinyl Estradiol—osteoporosis	0.0326	0.0508	CbGbCtD
Buprenorphine—CYP3A7-CYP3A51P—Estradiol—osteoporosis	0.0292	0.0454	CbGbCtD
Buprenorphine—CYP3A7—Estradiol—osteoporosis	0.0292	0.0454	CbGbCtD
Buprenorphine—CYP2C8—Cholecalciferol—osteoporosis	0.0261	0.0406	CbGbCtD
Buprenorphine—ABCB1—Ethinyl Estradiol—osteoporosis	0.0221	0.0344	CbGbCtD
Buprenorphine—CYP2C19—Cholecalciferol—osteoporosis	0.0219	0.0341	CbGbCtD
Buprenorphine—CYP3A5—Estradiol—osteoporosis	0.0219	0.0341	CbGbCtD
Buprenorphine—CYP2C8—Estradiol—osteoporosis	0.021	0.0327	CbGbCtD
Buprenorphine—CYP3A4—Estropipate—osteoporosis	0.0205	0.032	CbGbCtD
Buprenorphine—CYP3A4—Calcitriol—osteoporosis	0.0205	0.032	CbGbCtD
Buprenorphine—CYP1A2—Conjugated Estrogens—osteoporosis	0.0185	0.0289	CbGbCtD
Buprenorphine—CYP2C9—Cholecalciferol—osteoporosis	0.0182	0.0283	CbGbCtD
Buprenorphine—CYP2C19—Estradiol—osteoporosis	0.0176	0.0275	CbGbCtD
Buprenorphine—CYP2D6—Cholecalciferol—osteoporosis	0.0166	0.0259	CbGbCtD
Buprenorphine—CYP3A4—Ergocalciferol—osteoporosis	0.0164	0.0256	CbGbCtD
Buprenorphine—CYP1A2—Estradiol—osteoporosis	0.0163	0.0253	CbGbCtD
Buprenorphine—ABCB1—Conjugated Estrogens—osteoporosis	0.0162	0.0252	CbGbCtD
Buprenorphine—CYP2C9—Estradiol—osteoporosis	0.0147	0.0228	CbGbCtD
Buprenorphine—ABCB1—Estradiol—osteoporosis	0.0142	0.0222	CbGbCtD
Buprenorphine—CYP3A4—Raloxifene—osteoporosis	0.0137	0.0213	CbGbCtD
Buprenorphine—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0132	0.0206	CbGbCtD
Buprenorphine—CYP3A4—Cholecalciferol—osteoporosis	0.0106	0.0165	CbGbCtD
Buprenorphine—CYP3A4—Conjugated Estrogens—osteoporosis	0.00972	0.0151	CbGbCtD
Buprenorphine—CYP3A4—Estradiol—osteoporosis	0.00853	0.0133	CbGbCtD
Buprenorphine—Naloxone—ESR1—osteoporosis	0.000409	1	CrCbGaD
Buprenorphine—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000182	0.000622	CcSEcCtD
Buprenorphine—Fatigue—Ethinyl Estradiol—osteoporosis	0.000182	0.000621	CcSEcCtD
Buprenorphine—Pruritus—Alendronate—osteoporosis	0.000181	0.00062	CcSEcCtD
Buprenorphine—Dyspepsia—Risedronate—osteoporosis	0.000181	0.000619	CcSEcCtD
Buprenorphine—Eye disorder—Estradiol—osteoporosis	0.000181	0.000619	CcSEcCtD
Buprenorphine—Tinnitus—Estradiol—osteoporosis	0.00018	0.000617	CcSEcCtD
Buprenorphine—Constipation—Ethinyl Estradiol—osteoporosis	0.00018	0.000616	CcSEcCtD
Buprenorphine—Confusional state—Zoledronate—osteoporosis	0.00018	0.000615	CcSEcCtD
Buprenorphine—Hypersensitivity—Calcitriol—osteoporosis	0.00018	0.000615	CcSEcCtD
Buprenorphine—Flushing—Estradiol—osteoporosis	0.00018	0.000614	CcSEcCtD
Buprenorphine—Cardiac disorder—Estradiol—osteoporosis	0.00018	0.000614	CcSEcCtD
Buprenorphine—Chest pain—Conjugated Estrogens—osteoporosis	0.000179	0.000613	CcSEcCtD
Buprenorphine—Arthralgia—Conjugated Estrogens—osteoporosis	0.000179	0.000613	CcSEcCtD
Buprenorphine—Myalgia—Conjugated Estrogens—osteoporosis	0.000179	0.000613	CcSEcCtD
Buprenorphine—Asthenia—Ibandronate—osteoporosis	0.000179	0.000612	CcSEcCtD
Buprenorphine—Anxiety—Conjugated Estrogens—osteoporosis	0.000179	0.000611	CcSEcCtD
Buprenorphine—Nausea—Etidronic acid—osteoporosis	0.000178	0.000611	CcSEcCtD
Buprenorphine—Anaphylactic shock—Zoledronate—osteoporosis	0.000178	0.00061	CcSEcCtD
Buprenorphine—Oedema—Zoledronate—osteoporosis	0.000178	0.00061	CcSEcCtD
Buprenorphine—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000178	0.000609	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000178	0.000609	CcSEcCtD
Buprenorphine—Diarrhoea—Estropipate—osteoporosis	0.000178	0.000608	CcSEcCtD
Buprenorphine—Gastrointestinal disorder—Risedronate—osteoporosis	0.000177	0.000607	CcSEcCtD
Buprenorphine—Infection—Zoledronate—osteoporosis	0.000177	0.000606	CcSEcCtD
Buprenorphine—Fatigue—Risedronate—osteoporosis	0.000177	0.000606	CcSEcCtD
Buprenorphine—Insomnia—Pamidronate—osteoporosis	0.000177	0.000604	CcSEcCtD
Buprenorphine—Pruritus—Ibandronate—osteoporosis	0.000176	0.000603	CcSEcCtD
Buprenorphine—Constipation—Risedronate—osteoporosis	0.000176	0.000601	CcSEcCtD
Buprenorphine—Pain—Risedronate—osteoporosis	0.000176	0.000601	CcSEcCtD
Buprenorphine—Angiopathy—Estradiol—osteoporosis	0.000176	0.000601	CcSEcCtD
Buprenorphine—Shock—Zoledronate—osteoporosis	0.000175	0.0006	CcSEcCtD
Buprenorphine—Paraesthesia—Pamidronate—osteoporosis	0.000175	0.0006	CcSEcCtD
Buprenorphine—Diarrhoea—Alendronate—osteoporosis	0.000175	0.000599	CcSEcCtD
Buprenorphine—Asthenia—Calcitriol—osteoporosis	0.000175	0.000599	CcSEcCtD
Buprenorphine—Nervous system disorder—Zoledronate—osteoporosis	0.000175	0.000598	CcSEcCtD
Buprenorphine—Immune system disorder—Estradiol—osteoporosis	0.000175	0.000598	CcSEcCtD
Buprenorphine—Mediastinal disorder—Estradiol—osteoporosis	0.000174	0.000597	CcSEcCtD
Buprenorphine—Dyspnoea—Pamidronate—osteoporosis	0.000174	0.000596	CcSEcCtD
Buprenorphine—Tachycardia—Zoledronate—osteoporosis	0.000174	0.000596	CcSEcCtD
Buprenorphine—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000174	0.000594	CcSEcCtD
Buprenorphine—Chills—Estradiol—osteoporosis	0.000174	0.000594	CcSEcCtD
Buprenorphine—Somnolence—Pamidronate—osteoporosis	0.000174	0.000594	CcSEcCtD
Buprenorphine—Skin disorder—Zoledronate—osteoporosis	0.000173	0.000593	CcSEcCtD
Buprenorphine—Pruritus—Calcitriol—osteoporosis	0.000173	0.000591	CcSEcCtD
Buprenorphine—Hyperhidrosis—Zoledronate—osteoporosis	0.000172	0.00059	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000172	0.000589	CcSEcCtD
Buprenorphine—Diarrhoea—Raloxifene—osteoporosis	0.000172	0.000589	CcSEcCtD
Buprenorphine—Dyspepsia—Pamidronate—osteoporosis	0.000172	0.000588	CcSEcCtD
Buprenorphine—Dizziness—Estropipate—osteoporosis	0.000172	0.000588	CcSEcCtD
Buprenorphine—Oedema—Conjugated Estrogens—osteoporosis	0.000172	0.000588	CcSEcCtD
Buprenorphine—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000172	0.000588	CcSEcCtD
Buprenorphine—Infection—Conjugated Estrogens—osteoporosis	0.000171	0.000584	CcSEcCtD
Buprenorphine—Diarrhoea—Ibandronate—osteoporosis	0.000171	0.000583	CcSEcCtD
Buprenorphine—Anorexia—Zoledronate—osteoporosis	0.00017	0.000582	CcSEcCtD
Buprenorphine—Decreased appetite—Pamidronate—osteoporosis	0.00017	0.000581	CcSEcCtD
Buprenorphine—Mental disorder—Estradiol—osteoporosis	0.000169	0.00058	CcSEcCtD
Buprenorphine—Dizziness—Alendronate—osteoporosis	0.000169	0.000579	CcSEcCtD
Buprenorphine—Shock—Conjugated Estrogens—osteoporosis	0.000169	0.000578	CcSEcCtD
Buprenorphine—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000169	0.000577	CcSEcCtD
Buprenorphine—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000168	0.000576	CcSEcCtD
Buprenorphine—Erythema—Estradiol—osteoporosis	0.000168	0.000576	CcSEcCtD
Buprenorphine—Malnutrition—Estradiol—osteoporosis	0.000168	0.000576	CcSEcCtD
Buprenorphine—Fatigue—Pamidronate—osteoporosis	0.000168	0.000576	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Risedronate—osteoporosis	0.000168	0.000575	CcSEcCtD
Buprenorphine—Tachycardia—Conjugated Estrogens—osteoporosis	0.000168	0.000573	CcSEcCtD
Buprenorphine—Urticaria—Ethinyl Estradiol—osteoporosis	0.000167	0.000573	CcSEcCtD
Buprenorphine—Constipation—Pamidronate—osteoporosis	0.000167	0.000571	CcSEcCtD
Buprenorphine—Pain—Pamidronate—osteoporosis	0.000167	0.000571	CcSEcCtD
Buprenorphine—Diarrhoea—Calcitriol—osteoporosis	0.000167	0.000571	CcSEcCtD
Buprenorphine—Skin disorder—Conjugated Estrogens—osteoporosis	0.000167	0.000571	CcSEcCtD
Buprenorphine—Hypotension—Zoledronate—osteoporosis	0.000167	0.00057	CcSEcCtD
Buprenorphine—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000167	0.00057	CcSEcCtD
Buprenorphine—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000167	0.00057	CcSEcCtD
Buprenorphine—Dizziness—Raloxifene—osteoporosis	0.000166	0.00057	CcSEcCtD
Buprenorphine—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000166	0.000568	CcSEcCtD
Buprenorphine—Flatulence—Estradiol—osteoporosis	0.000166	0.000568	CcSEcCtD
Buprenorphine—Tension—Estradiol—osteoporosis	0.000165	0.000565	CcSEcCtD
Buprenorphine—Vomiting—Estropipate—osteoporosis	0.000165	0.000565	CcSEcCtD
Buprenorphine—Dysgeusia—Estradiol—osteoporosis	0.000165	0.000564	CcSEcCtD
Buprenorphine—Dizziness—Ibandronate—osteoporosis	0.000165	0.000564	CcSEcCtD
Buprenorphine—Rash—Estropipate—osteoporosis	0.000164	0.000561	CcSEcCtD
Buprenorphine—Dermatitis—Estropipate—osteoporosis	0.000164	0.00056	CcSEcCtD
Buprenorphine—Anorexia—Conjugated Estrogens—osteoporosis	0.000164	0.00056	CcSEcCtD
Buprenorphine—Nervousness—Estradiol—osteoporosis	0.000164	0.00056	CcSEcCtD
Buprenorphine—Urticaria—Risedronate—osteoporosis	0.000163	0.000558	CcSEcCtD
Buprenorphine—Back pain—Estradiol—osteoporosis	0.000163	0.000557	CcSEcCtD
Buprenorphine—Headache—Estropipate—osteoporosis	0.000163	0.000557	CcSEcCtD
Buprenorphine—Vomiting—Alendronate—osteoporosis	0.000163	0.000557	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000162	0.000556	CcSEcCtD
Buprenorphine—Abdominal pain—Risedronate—osteoporosis	0.000162	0.000556	CcSEcCtD
Buprenorphine—Body temperature increased—Risedronate—osteoporosis	0.000162	0.000556	CcSEcCtD
Buprenorphine—Muscle spasms—Estradiol—osteoporosis	0.000162	0.000554	CcSEcCtD
Buprenorphine—Rash—Alendronate—osteoporosis	0.000161	0.000552	CcSEcCtD
Buprenorphine—Insomnia—Zoledronate—osteoporosis	0.000161	0.000552	CcSEcCtD
Buprenorphine—Dermatitis—Alendronate—osteoporosis	0.000161	0.000552	CcSEcCtD
Buprenorphine—Feeling abnormal—Pamidronate—osteoporosis	0.000161	0.00055	CcSEcCtD
Buprenorphine—Hypotension—Conjugated Estrogens—osteoporosis	0.00016	0.000549	CcSEcCtD
Buprenorphine—Headache—Alendronate—osteoporosis	0.00016	0.000549	CcSEcCtD
Buprenorphine—Paraesthesia—Zoledronate—osteoporosis	0.00016	0.000548	CcSEcCtD
Buprenorphine—Vomiting—Raloxifene—osteoporosis	0.00016	0.000548	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Pamidronate—osteoporosis	0.00016	0.000546	CcSEcCtD
Buprenorphine—Dyspnoea—Zoledronate—osteoporosis	0.000159	0.000544	CcSEcCtD
Buprenorphine—Rash—Raloxifene—osteoporosis	0.000159	0.000543	CcSEcCtD
Buprenorphine—Dermatitis—Raloxifene—osteoporosis	0.000159	0.000543	CcSEcCtD
Buprenorphine—Somnolence—Zoledronate—osteoporosis	0.000159	0.000542	CcSEcCtD
Buprenorphine—Vomiting—Ibandronate—osteoporosis	0.000158	0.000542	CcSEcCtD
Buprenorphine—Tremor—Estradiol—osteoporosis	0.000158	0.00054	CcSEcCtD
Buprenorphine—Headache—Raloxifene—osteoporosis	0.000158	0.00054	CcSEcCtD
Buprenorphine—Rash—Ibandronate—osteoporosis	0.000157	0.000538	CcSEcCtD
Buprenorphine—Dermatitis—Ibandronate—osteoporosis	0.000157	0.000537	CcSEcCtD
Buprenorphine—Dyspepsia—Zoledronate—osteoporosis	0.000157	0.000537	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000156	0.000535	CcSEcCtD
Buprenorphine—Ill-defined disorder—Estradiol—osteoporosis	0.000156	0.000535	CcSEcCtD
Buprenorphine—Headache—Ibandronate—osteoporosis	0.000156	0.000534	CcSEcCtD
Buprenorphine—Insomnia—Conjugated Estrogens—osteoporosis	0.000155	0.000531	CcSEcCtD
Buprenorphine—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000155	0.000531	CcSEcCtD
Buprenorphine—Vomiting—Calcitriol—osteoporosis	0.000155	0.000531	CcSEcCtD
Buprenorphine—Decreased appetite—Zoledronate—osteoporosis	0.000155	0.00053	CcSEcCtD
Buprenorphine—Agitation—Estradiol—osteoporosis	0.000155	0.000529	CcSEcCtD
Buprenorphine—Nausea—Estropipate—osteoporosis	0.000154	0.000528	CcSEcCtD
Buprenorphine—Abdominal pain—Pamidronate—osteoporosis	0.000154	0.000528	CcSEcCtD
Buprenorphine—Body temperature increased—Pamidronate—osteoporosis	0.000154	0.000528	CcSEcCtD
Buprenorphine—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000154	0.000528	CcSEcCtD
Buprenorphine—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000154	0.000527	CcSEcCtD
Buprenorphine—Angioedema—Estradiol—osteoporosis	0.000154	0.000526	CcSEcCtD
Buprenorphine—Rash—Calcitriol—osteoporosis	0.000154	0.000526	CcSEcCtD
Buprenorphine—Fatigue—Zoledronate—osteoporosis	0.000154	0.000526	CcSEcCtD
Buprenorphine—Dermatitis—Calcitriol—osteoporosis	0.000154	0.000526	CcSEcCtD
Buprenorphine—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000153	0.000524	CcSEcCtD
Buprenorphine—Headache—Calcitriol—osteoporosis	0.000153	0.000523	CcSEcCtD
Buprenorphine—Somnolence—Conjugated Estrogens—osteoporosis	0.000153	0.000522	CcSEcCtD
Buprenorphine—Pain—Zoledronate—osteoporosis	0.000153	0.000522	CcSEcCtD
Buprenorphine—Constipation—Zoledronate—osteoporosis	0.000153	0.000522	CcSEcCtD
Buprenorphine—Nausea—Alendronate—osteoporosis	0.000152	0.00052	CcSEcCtD
Buprenorphine—Malaise—Estradiol—osteoporosis	0.000152	0.00052	CcSEcCtD
Buprenorphine—Hypersensitivity—Risedronate—osteoporosis	0.000151	0.000518	CcSEcCtD
Buprenorphine—Vertigo—Estradiol—osteoporosis	0.000151	0.000518	CcSEcCtD
Buprenorphine—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000151	0.000517	CcSEcCtD
Buprenorphine—Asthenia—Ethinyl Estradiol—osteoporosis	0.000151	0.000517	CcSEcCtD
Buprenorphine—Syncope—Estradiol—osteoporosis	0.000151	0.000517	CcSEcCtD
Buprenorphine—Nausea—Raloxifene—osteoporosis	0.00015	0.000512	CcSEcCtD
Buprenorphine—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000149	0.000511	CcSEcCtD
Buprenorphine—Pruritus—Ethinyl Estradiol—osteoporosis	0.000149	0.00051	CcSEcCtD
Buprenorphine—Palpitations—Estradiol—osteoporosis	0.000149	0.000509	CcSEcCtD
Buprenorphine—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000148	0.000507	CcSEcCtD
Buprenorphine—Fatigue—Conjugated Estrogens—osteoporosis	0.000148	0.000507	CcSEcCtD
Buprenorphine—Nausea—Ibandronate—osteoporosis	0.000148	0.000506	CcSEcCtD
Buprenorphine—Loss of consciousness—Estradiol—osteoporosis	0.000148	0.000506	CcSEcCtD
Buprenorphine—Asthenia—Risedronate—osteoporosis	0.000147	0.000504	CcSEcCtD
Buprenorphine—Feeling abnormal—Zoledronate—osteoporosis	0.000147	0.000503	CcSEcCtD
Buprenorphine—Cough—Estradiol—osteoporosis	0.000147	0.000503	CcSEcCtD
Buprenorphine—Pain—Conjugated Estrogens—osteoporosis	0.000147	0.000502	CcSEcCtD
Buprenorphine—Constipation—Conjugated Estrogens—osteoporosis	0.000147	0.000502	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Zoledronate—osteoporosis	0.000146	0.000499	CcSEcCtD
Buprenorphine—Hypertension—Estradiol—osteoporosis	0.000145	0.000497	CcSEcCtD
Buprenorphine—Pruritus—Risedronate—osteoporosis	0.000145	0.000497	CcSEcCtD
Buprenorphine—Nausea—Calcitriol—osteoporosis	0.000145	0.000496	CcSEcCtD
Buprenorphine—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000144	0.000493	CcSEcCtD
Buprenorphine—Hypersensitivity—Pamidronate—osteoporosis	0.000144	0.000492	CcSEcCtD
Buprenorphine—Arthralgia—Estradiol—osteoporosis	0.000143	0.000491	CcSEcCtD
Buprenorphine—Myalgia—Estradiol—osteoporosis	0.000143	0.000491	CcSEcCtD
Buprenorphine—Chest pain—Estradiol—osteoporosis	0.000143	0.000491	CcSEcCtD
Buprenorphine—Anxiety—Estradiol—osteoporosis	0.000143	0.000489	CcSEcCtD
Buprenorphine—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000142	0.000487	CcSEcCtD
Buprenorphine—Urticaria—Zoledronate—osteoporosis	0.000142	0.000485	CcSEcCtD
Buprenorphine—Discomfort—Estradiol—osteoporosis	0.000142	0.000485	CcSEcCtD
Buprenorphine—Abdominal pain—Zoledronate—osteoporosis	0.000141	0.000482	CcSEcCtD
Buprenorphine—Body temperature increased—Zoledronate—osteoporosis	0.000141	0.000482	CcSEcCtD
Buprenorphine—Diarrhoea—Risedronate—osteoporosis	0.000141	0.000481	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.00014	0.00048	CcSEcCtD
Buprenorphine—Dry mouth—Estradiol—osteoporosis	0.00014	0.00048	CcSEcCtD
Buprenorphine—Asthenia—Pamidronate—osteoporosis	0.00014	0.000479	CcSEcCtD
Buprenorphine—Dizziness—Ethinyl Estradiol—osteoporosis	0.000139	0.000477	CcSEcCtD
Buprenorphine—Confusional state—Estradiol—osteoporosis	0.000139	0.000474	CcSEcCtD
Buprenorphine—Pruritus—Pamidronate—osteoporosis	0.000138	0.000473	CcSEcCtD
Buprenorphine—Oedema—Estradiol—osteoporosis	0.000137	0.00047	CcSEcCtD
Buprenorphine—Anaphylactic shock—Estradiol—osteoporosis	0.000137	0.00047	CcSEcCtD
Buprenorphine—Infection—Estradiol—osteoporosis	0.000137	0.000467	CcSEcCtD
Buprenorphine—Urticaria—Conjugated Estrogens—osteoporosis	0.000136	0.000467	CcSEcCtD
Buprenorphine—Dizziness—Risedronate—osteoporosis	0.000136	0.000465	CcSEcCtD
Buprenorphine—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000136	0.000464	CcSEcCtD
Buprenorphine—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000136	0.000464	CcSEcCtD
Buprenorphine—Shock—Estradiol—osteoporosis	0.000135	0.000463	CcSEcCtD
Buprenorphine—Nervous system disorder—Estradiol—osteoporosis	0.000135	0.000461	CcSEcCtD
Buprenorphine—Tachycardia—Estradiol—osteoporosis	0.000134	0.000459	CcSEcCtD
Buprenorphine—Vomiting—Ethinyl Estradiol—osteoporosis	0.000134	0.000458	CcSEcCtD
Buprenorphine—Diarrhoea—Pamidronate—osteoporosis	0.000134	0.000457	CcSEcCtD
Buprenorphine—Skin disorder—Estradiol—osteoporosis	0.000133	0.000457	CcSEcCtD
Buprenorphine—Hyperhidrosis—Estradiol—osteoporosis	0.000133	0.000455	CcSEcCtD
Buprenorphine—Rash—Ethinyl Estradiol—osteoporosis	0.000133	0.000454	CcSEcCtD
Buprenorphine—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000133	0.000454	CcSEcCtD
Buprenorphine—Headache—Ethinyl Estradiol—osteoporosis	0.000132	0.000452	CcSEcCtD
Buprenorphine—Hypersensitivity—Zoledronate—osteoporosis	0.000131	0.00045	CcSEcCtD
Buprenorphine—Vomiting—Risedronate—osteoporosis	0.000131	0.000447	CcSEcCtD
Buprenorphine—Rash—Risedronate—osteoporosis	0.000129	0.000443	CcSEcCtD
Buprenorphine—Dermatitis—Risedronate—osteoporosis	0.000129	0.000443	CcSEcCtD
Buprenorphine—Dizziness—Pamidronate—osteoporosis	0.000129	0.000442	CcSEcCtD
Buprenorphine—Headache—Risedronate—osteoporosis	0.000129	0.00044	CcSEcCtD
Buprenorphine—Asthenia—Zoledronate—osteoporosis	0.000128	0.000438	CcSEcCtD
Buprenorphine—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000127	0.000433	CcSEcCtD
Buprenorphine—Pruritus—Zoledronate—osteoporosis	0.000126	0.000432	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000125	0.000428	CcSEcCtD
Buprenorphine—Nausea—Ethinyl Estradiol—osteoporosis	0.000125	0.000428	CcSEcCtD
Buprenorphine—Insomnia—Estradiol—osteoporosis	0.000124	0.000425	CcSEcCtD
Buprenorphine—Vomiting—Pamidronate—osteoporosis	0.000124	0.000425	CcSEcCtD
Buprenorphine—Paraesthesia—Estradiol—osteoporosis	0.000123	0.000422	CcSEcCtD
Buprenorphine—Asthenia—Conjugated Estrogens—osteoporosis	0.000123	0.000422	CcSEcCtD
Buprenorphine—Rash—Pamidronate—osteoporosis	0.000123	0.000421	CcSEcCtD
Buprenorphine—Dermatitis—Pamidronate—osteoporosis	0.000123	0.000421	CcSEcCtD
Buprenorphine—Dyspnoea—Estradiol—osteoporosis	0.000123	0.000419	CcSEcCtD
Buprenorphine—Headache—Pamidronate—osteoporosis	0.000122	0.000418	CcSEcCtD
Buprenorphine—Somnolence—Estradiol—osteoporosis	0.000122	0.000418	CcSEcCtD
Buprenorphine—Diarrhoea—Zoledronate—osteoporosis	0.000122	0.000417	CcSEcCtD
Buprenorphine—Nausea—Risedronate—osteoporosis	0.000122	0.000417	CcSEcCtD
Buprenorphine—Pruritus—Conjugated Estrogens—osteoporosis	0.000121	0.000416	CcSEcCtD
Buprenorphine—Dyspepsia—Estradiol—osteoporosis	0.000121	0.000414	CcSEcCtD
Buprenorphine—Decreased appetite—Estradiol—osteoporosis	0.000119	0.000409	CcSEcCtD
Buprenorphine—Gastrointestinal disorder—Estradiol—osteoporosis	0.000119	0.000406	CcSEcCtD
Buprenorphine—Fatigue—Estradiol—osteoporosis	0.000118	0.000405	CcSEcCtD
Buprenorphine—Dizziness—Zoledronate—osteoporosis	0.000118	0.000404	CcSEcCtD
Buprenorphine—Constipation—Estradiol—osteoporosis	0.000118	0.000402	CcSEcCtD
Buprenorphine—Pain—Estradiol—osteoporosis	0.000118	0.000402	CcSEcCtD
Buprenorphine—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000117	0.000402	CcSEcCtD
Buprenorphine—Nausea—Pamidronate—osteoporosis	0.000116	0.000397	CcSEcCtD
Buprenorphine—Dizziness—Conjugated Estrogens—osteoporosis	0.000114	0.000389	CcSEcCtD
Buprenorphine—Vomiting—Zoledronate—osteoporosis	0.000113	0.000388	CcSEcCtD
Buprenorphine—Feeling abnormal—Estradiol—osteoporosis	0.000113	0.000388	CcSEcCtD
Buprenorphine—Rash—Zoledronate—osteoporosis	0.000112	0.000385	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Estradiol—osteoporosis	0.000112	0.000385	CcSEcCtD
Buprenorphine—Dermatitis—Zoledronate—osteoporosis	0.000112	0.000384	CcSEcCtD
Buprenorphine—Headache—Zoledronate—osteoporosis	0.000112	0.000382	CcSEcCtD
Buprenorphine—Vomiting—Conjugated Estrogens—osteoporosis	0.000109	0.000374	CcSEcCtD
Buprenorphine—Urticaria—Estradiol—osteoporosis	0.000109	0.000374	CcSEcCtD
Buprenorphine—Body temperature increased—Estradiol—osteoporosis	0.000109	0.000372	CcSEcCtD
Buprenorphine—Abdominal pain—Estradiol—osteoporosis	0.000109	0.000372	CcSEcCtD
Buprenorphine—Rash—Conjugated Estrogens—osteoporosis	0.000108	0.00037	CcSEcCtD
Buprenorphine—Dermatitis—Conjugated Estrogens—osteoporosis	0.000108	0.00037	CcSEcCtD
Buprenorphine—Headache—Conjugated Estrogens—osteoporosis	0.000108	0.000368	CcSEcCtD
Buprenorphine—Nausea—Zoledronate—osteoporosis	0.000106	0.000362	CcSEcCtD
Buprenorphine—Nausea—Conjugated Estrogens—osteoporosis	0.000102	0.000349	CcSEcCtD
Buprenorphine—Hypersensitivity—Estradiol—osteoporosis	0.000101	0.000346	CcSEcCtD
Buprenorphine—Asthenia—Estradiol—osteoporosis	9.86e-05	0.000337	CcSEcCtD
Buprenorphine—Pruritus—Estradiol—osteoporosis	9.72e-05	0.000333	CcSEcCtD
Buprenorphine—Diarrhoea—Estradiol—osteoporosis	9.4e-05	0.000322	CcSEcCtD
Buprenorphine—Dizziness—Estradiol—osteoporosis	9.09e-05	0.000311	CcSEcCtD
Buprenorphine—Vomiting—Estradiol—osteoporosis	8.74e-05	0.000299	CcSEcCtD
Buprenorphine—Rash—Estradiol—osteoporosis	8.67e-05	0.000296	CcSEcCtD
Buprenorphine—Dermatitis—Estradiol—osteoporosis	8.66e-05	0.000296	CcSEcCtD
Buprenorphine—Headache—Estradiol—osteoporosis	8.61e-05	0.000295	CcSEcCtD
Buprenorphine—Nausea—Estradiol—osteoporosis	8.16e-05	0.000279	CcSEcCtD
Buprenorphine—CYP3A5—Metabolism—ACP5—osteoporosis	2.24e-05	0.000346	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—POMC—osteoporosis	2.24e-05	0.000345	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—OXCT1—osteoporosis	2.23e-05	0.000344	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—CA2—osteoporosis	2.23e-05	0.000344	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—MGLL—osteoporosis	2.23e-05	0.000344	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—CALCA—osteoporosis	2.22e-05	0.000341	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—IL6R—osteoporosis	2.18e-05	0.000336	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—MGLL—osteoporosis	2.18e-05	0.000336	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—POMC—osteoporosis	2.16e-05	0.000333	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—PTHLH—osteoporosis	2.13e-05	0.000328	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—BMP2—osteoporosis	2.13e-05	0.000328	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—IDH2—osteoporosis	2.13e-05	0.000328	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—ENO1—osteoporosis	2.12e-05	0.000326	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—OXCT1—osteoporosis	2.11e-05	0.000324	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—CA2—osteoporosis	2.11e-05	0.000324	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.1e-05	0.000324	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—ATIC—osteoporosis	2.1e-05	0.000323	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—PNP—osteoporosis	2.1e-05	0.000323	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—ENO1—osteoporosis	2.1e-05	0.000323	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—CA2—osteoporosis	2.09e-05	0.000322	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—OXCT1—osteoporosis	2.09e-05	0.000322	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—TPI1—osteoporosis	2.09e-05	0.000322	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—PSMA2—osteoporosis	2.08e-05	0.000321	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—PSMA5—osteoporosis	2.08e-05	0.000321	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—FGB—osteoporosis	2.08e-05	0.000321	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—PSMA5—osteoporosis	2.07e-05	0.000318	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—PSMA2—osteoporosis	2.07e-05	0.000318	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—ADCY5—osteoporosis	2.06e-05	0.000318	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—GPX1—osteoporosis	2.05e-05	0.000316	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—MGLL—osteoporosis	2.05e-05	0.000316	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—MGLL—osteoporosis	2.03e-05	0.000313	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—KL—osteoporosis	2.01e-05	0.00031	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—PSMA5—osteoporosis	2.01e-05	0.00031	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—PSMA2—osteoporosis	2.01e-05	0.00031	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—CYP27A1—osteoporosis	2e-05	0.000308	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—CYP19A1—osteoporosis	1.99e-05	0.000307	CbGpPWpGaD
Buprenorphine—CYP3A4—Biological oxidations—POMC—osteoporosis	1.98e-05	0.000305	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—POMC—osteoporosis	1.96e-05	0.000302	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—P4HB—osteoporosis	1.96e-05	0.000302	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—ACP5—osteoporosis	1.94e-05	0.0003	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—GAPDH—osteoporosis	1.93e-05	0.000297	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—ENO1—osteoporosis	1.92e-05	0.000296	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.92e-05	0.000296	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.92e-05	0.000296	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—IL6R—osteoporosis	1.91e-05	0.000295	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—IDH2—osteoporosis	1.9e-05	0.000292	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—MTHFR—osteoporosis	1.9e-05	0.000292	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—PSMA2—osteoporosis	1.89e-05	0.000292	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—PSMA5—osteoporosis	1.89e-05	0.000292	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—RAP1A—osteoporosis	1.88e-05	0.000289	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—CALCA—osteoporosis	1.87e-05	0.000289	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—PKM—osteoporosis	1.87e-05	0.000288	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—FDPS—osteoporosis	1.87e-05	0.000288	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—IDH2—osteoporosis	1.85e-05	0.000285	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—POMC—osteoporosis	1.83e-05	0.000281	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—TPI1—osteoporosis	1.81e-05	0.000278	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—ADCY5—osteoporosis	1.8e-05	0.000277	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—MYC—osteoporosis	1.79e-05	0.000276	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—TGFB1—osteoporosis	1.79e-05	0.000275	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—OXCT1—osteoporosis	1.78e-05	0.000275	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—CA2—osteoporosis	1.78e-05	0.000275	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—CYP27A1—osteoporosis	1.78e-05	0.000275	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—PGLS—osteoporosis	1.77e-05	0.000273	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—GPD2—osteoporosis	1.77e-05	0.000273	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—IDH2—osteoporosis	1.74e-05	0.000269	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—CYP27A1—osteoporosis	1.74e-05	0.000268	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—SPP1—osteoporosis	1.74e-05	0.000268	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—MGLL—osteoporosis	1.74e-05	0.000268	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—ACP5—osteoporosis	1.74e-05	0.000267	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—IDH2—osteoporosis	1.73e-05	0.000267	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.71e-05	0.000264	CbGpPWpGaD
Buprenorphine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	1.71e-05	0.000263	CbGpPWpGaD
Buprenorphine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	1.7e-05	0.000263	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—KL—osteoporosis	1.7e-05	0.000262	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—P4HB—osteoporosis	1.7e-05	0.000262	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—ACP5—osteoporosis	1.69e-05	0.000261	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—CYP19A1—osteoporosis	1.69e-05	0.000261	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—CYP19A1—osteoporosis	1.68e-05	0.000258	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—GAPDH—osteoporosis	1.67e-05	0.000257	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—POMC—osteoporosis	1.66e-05	0.000256	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—CYP27A1—osteoporosis	1.64e-05	0.000253	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.64e-05	0.000253	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—ADCY5—osteoporosis	1.63e-05	0.000251	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—CYP27A1—osteoporosis	1.63e-05	0.000251	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—RAP1A—osteoporosis	1.62e-05	0.00025	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—GPX1—osteoporosis	1.62e-05	0.00025	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—ATIC—osteoporosis	1.62e-05	0.00025	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—PNP—osteoporosis	1.62e-05	0.00025	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—IL6R—osteoporosis	1.62e-05	0.000249	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—TPI1—osteoporosis	1.61e-05	0.000249	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—ACP5—osteoporosis	1.6e-05	0.000246	CbGpPWpGaD
Buprenorphine—ABCB1—Transmembrane transport of small molecules—ADCY5—osteoporosis	1.6e-05	0.000246	CbGpPWpGaD
Buprenorphine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	1.59e-05	0.000245	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—ACP5—osteoporosis	1.58e-05	0.000244	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—ADCY5—osteoporosis	1.58e-05	0.000243	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—TPI1—osteoporosis	1.57e-05	0.000243	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—IRS2—osteoporosis	1.57e-05	0.000242	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.56e-05	0.000241	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—LEP—osteoporosis	1.54e-05	0.000237	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—CYP19A1—osteoporosis	1.54e-05	0.000237	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—SPP1—osteoporosis	1.52e-05	0.000235	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—P4HB—osteoporosis	1.52e-05	0.000234	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—ENO1—osteoporosis	1.52e-05	0.000234	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—POMC—osteoporosis	1.52e-05	0.000234	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—MTHFR—osteoporosis	1.5e-05	0.000231	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—PSMA2—osteoporosis	1.49e-05	0.00023	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—PSMA5—osteoporosis	1.49e-05	0.00023	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—GAPDH—osteoporosis	1.49e-05	0.000229	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—TPI1—osteoporosis	1.48e-05	0.000229	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—P4HB—osteoporosis	1.48e-05	0.000228	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—IDH2—osteoporosis	1.48e-05	0.000228	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—TPI1—osteoporosis	1.47e-05	0.000227	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—ESR1—osteoporosis	1.47e-05	0.000226	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—GAPDH—osteoporosis	1.45e-05	0.000224	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—RAP1A—osteoporosis	1.45e-05	0.000223	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.42e-05	0.000218	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—RAP1A—osteoporosis	1.42e-05	0.000218	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—P4HB—osteoporosis	1.39e-05	0.000215	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—CYP27A1—osteoporosis	1.39e-05	0.000214	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—P4HB—osteoporosis	1.38e-05	0.000213	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—ADCY5—osteoporosis	1.38e-05	0.000213	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—IRS2—osteoporosis	1.38e-05	0.000212	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—GPX1—osteoporosis	1.38e-05	0.000212	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—CA2—osteoporosis	1.38e-05	0.000212	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—OXCT1—osteoporosis	1.38e-05	0.000212	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—IRS1—osteoporosis	1.37e-05	0.000212	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—ADCY5—osteoporosis	1.37e-05	0.000211	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—GAPDH—osteoporosis	1.37e-05	0.000211	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—GPX1—osteoporosis	1.37e-05	0.00021	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—GAPDH—osteoporosis	1.36e-05	0.000209	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—ACP5—osteoporosis	1.35e-05	0.000208	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—LEP—osteoporosis	1.35e-05	0.000208	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—IL6—osteoporosis	1.35e-05	0.000207	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—MGLL—osteoporosis	1.34e-05	0.000207	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.33e-05	0.000206	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—RAP1A—osteoporosis	1.33e-05	0.000205	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—ADCY5—osteoporosis	1.33e-05	0.000205	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—RAP1A—osteoporosis	1.32e-05	0.000204	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—POMC—osteoporosis	1.32e-05	0.000204	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—ENO1—osteoporosis	1.31e-05	0.000202	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—PSMA2—osteoporosis	1.29e-05	0.000199	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—PSMA5—osteoporosis	1.29e-05	0.000199	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—IL6R—osteoporosis	1.29e-05	0.000199	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—SPP1—osteoporosis	1.29e-05	0.000199	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—ESR1—osteoporosis	1.29e-05	0.000199	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—IGF1—osteoporosis	1.27e-05	0.000196	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—MTHFR—osteoporosis	1.27e-05	0.000196	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.26e-05	0.000195	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—MTHFR—osteoporosis	1.26e-05	0.000194	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—TPI1—osteoporosis	1.26e-05	0.000194	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—ADCY5—osteoporosis	1.26e-05	0.000193	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—GPX1—osteoporosis	1.25e-05	0.000193	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—CYP19A1—osteoporosis	1.21e-05	0.000187	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—IRS1—osteoporosis	1.2e-05	0.000185	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—POMC—osteoporosis	1.2e-05	0.000185	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—P4HB—osteoporosis	1.18e-05	0.000182	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—ENO1—osteoporosis	1.17e-05	0.000181	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—IRS2—osteoporosis	1.17e-05	0.00018	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—GAPDH—osteoporosis	1.16e-05	0.000179	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—POMC—osteoporosis	1.16e-05	0.000179	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—PSMA5—osteoporosis	1.15e-05	0.000178	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—PSMA2—osteoporosis	1.15e-05	0.000178	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—MTHFR—osteoporosis	1.15e-05	0.000178	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.15e-05	0.000178	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—ENO1—osteoporosis	1.14e-05	0.000176	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—IDH2—osteoporosis	1.14e-05	0.000176	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—LEP—osteoporosis	1.14e-05	0.000176	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—IL6R—osteoporosis	1.13e-05	0.000174	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—RAP1A—osteoporosis	1.13e-05	0.000174	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—PSMA2—osteoporosis	1.13e-05	0.000174	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—PSMA5—osteoporosis	1.13e-05	0.000174	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—IGF1—osteoporosis	1.11e-05	0.000172	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—ESR1—osteoporosis	1.09e-05	0.000168	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—ENO1—osteoporosis	1.08e-05	0.000166	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—CYP27A1—osteoporosis	1.07e-05	0.000165	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—ENO1—osteoporosis	1.07e-05	0.000165	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—PSMA5—osteoporosis	1.06e-05	0.000164	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—PSMA2—osteoporosis	1.06e-05	0.000164	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—PSMA2—osteoporosis	1.05e-05	0.000162	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—PSMA5—osteoporosis	1.05e-05	0.000162	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—CYP19A1—osteoporosis	1.05e-05	0.000162	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—ACP5—osteoporosis	1.04e-05	0.000161	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—IRS1—osteoporosis	1.02e-05	0.000157	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—POMC—osteoporosis	1.02e-05	0.000157	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—POMC—osteoporosis	1.01e-05	0.000155	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—ADCY5—osteoporosis	9.9e-06	0.000153	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—GPX1—osteoporosis	9.87e-06	0.000152	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	9.85e-06	0.000152	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—POMC—osteoporosis	9.8e-06	0.000151	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—IL6—osteoporosis	9.72e-06	0.00015	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—TPI1—osteoporosis	9.7e-06	0.000149	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—IL6R—osteoporosis	9.56e-06	0.000147	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—IGF1—osteoporosis	9.42e-06	0.000145	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—CYP19A1—osteoporosis	9.37e-06	0.000144	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—POMC—osteoporosis	9.24e-06	0.000142	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—CYP19A1—osteoporosis	9.15e-06	0.000141	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—ENO1—osteoporosis	9.13e-06	0.000141	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—P4HB—osteoporosis	9.12e-06	0.000141	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—MTHFR—osteoporosis	9.11e-06	0.00014	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—PSMA2—osteoporosis	9e-06	0.000139	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—PSMA5—osteoporosis	9e-06	0.000139	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—GAPDH—osteoporosis	8.95e-06	0.000138	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—RAP1A—osteoporosis	8.72e-06	0.000134	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—CYP19A1—osteoporosis	8.62e-06	0.000133	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—ADCY5—osteoporosis	8.58e-06	0.000132	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—GPX1—osteoporosis	8.55e-06	0.000132	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—CYP19A1—osteoporosis	8.54e-06	0.000132	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—IL6—osteoporosis	8.53e-06	0.000131	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—MTHFR—osteoporosis	7.89e-06	0.000122	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—ADCY5—osteoporosis	7.66e-06	0.000118	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—MYC—osteoporosis	7.64e-06	0.000118	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—GPX1—osteoporosis	7.63e-06	0.000118	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—TGFB1—osteoporosis	7.62e-06	0.000117	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—ADCY5—osteoporosis	7.47e-06	0.000115	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—GPX1—osteoporosis	7.45e-06	0.000115	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—CYP19A1—osteoporosis	7.3e-06	0.000113	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—POMC—osteoporosis	7.28e-06	0.000112	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—IL6—osteoporosis	7.21e-06	0.000111	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—ENO1—osteoporosis	7.05e-06	0.000109	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—ADCY5—osteoporosis	7.04e-06	0.000109	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—MTHFR—osteoporosis	7.04e-06	0.000108	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—GPX1—osteoporosis	7.02e-06	0.000108	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—ADCY5—osteoporosis	6.98e-06	0.000108	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—GPX1—osteoporosis	6.96e-06	0.000107	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—PSMA2—osteoporosis	6.95e-06	0.000107	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—PSMA5—osteoporosis	6.95e-06	0.000107	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—MTHFR—osteoporosis	6.87e-06	0.000106	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—MYC—osteoporosis	6.7e-06	0.000103	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—TGFB1—osteoporosis	6.68e-06	0.000103	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—MTHFR—osteoporosis	6.48e-06	9.98e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—MTHFR—osteoporosis	6.42e-06	9.89e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—POMC—osteoporosis	6.31e-06	9.72e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—ADCY5—osteoporosis	5.97e-06	9.19e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—GPX1—osteoporosis	5.94e-06	9.16e-05	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—IL6—osteoporosis	5.74e-06	8.85e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—MYC—osteoporosis	5.66e-06	8.73e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—TGFB1—osteoporosis	5.65e-06	8.71e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—CYP19A1—osteoporosis	5.63e-06	8.68e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—POMC—osteoporosis	5.63e-06	8.68e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—POMC—osteoporosis	5.5e-06	8.47e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—MTHFR—osteoporosis	5.49e-06	8.45e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—POMC—osteoporosis	5.18e-06	7.98e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—POMC—osteoporosis	5.13e-06	7.91e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—IL6—osteoporosis	5.04e-06	7.76e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—ADCY5—osteoporosis	4.6e-06	7.09e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—GPX1—osteoporosis	4.59e-06	7.07e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—POMC—osteoporosis	4.39e-06	6.76e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—IL6—osteoporosis	4.26e-06	6.56e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—MTHFR—osteoporosis	4.23e-06	6.52e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—POMC—osteoporosis	3.39e-06	5.22e-05	CbGpPWpGaD
